Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP-X: Conversion to Advagraf in Kidney Transplant Recipients
NCT03751332Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2008
- Primary completion
- Oct 2010
01
Overview
Phase 4, open-label trial of tacrolimus in kidney transplantation, sponsored by Medical University of Vienna. Primary endpoint: Trough blood levels of tacrolimus at 12 months. Started Mar 2008; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT03751332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03751332.